surrounding area
Semaglutide, FDA‑approved in 2021, targets appetite, digestion speed, and blood sugar to aid weight loss. Suitable for adults with BMI ≥30 or ≥27 plus conditions like type 2 diabetes, hypertension, or high cholesterol. Clinical data show average 16.7% body‑weight loss over two years, with weekly injections and regular monitoring under medical supervision.